150 related articles for article (PubMed ID: 20015925)
1. Pharmacokinetics of vancomycin in adult cancer patients.
Al-Kofide H; Zaghloul I; Al-Naim L
J Oncol Pharm Pract; 2010 Dec; 16(4):245-50. PubMed ID: 20015925
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetic analysis of vancomycin in patients with gram-positive infections and the influence of infectious disease type.
Yamamoto M; Kuzuya T; Baba H; Yamada K; Nabeshima T
J Clin Pharm Ther; 2009 Aug; 34(4):473-83. PubMed ID: 19583681
[TBL] [Abstract][Full Text] [Related]
3. Reduced vancomycin clearance despite unchanged creatinine clearance in patients treated with vancomycin for longer than 4 weeks.
Nakayama H; Echizen H; Tanaka M; Sato M; Orii T
Ther Drug Monit; 2008 Feb; 30(1):103-7. PubMed ID: 18223471
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the prediction accuracy of vancomycin concentrations determined by patient-specific parameters as estimated by Bayesian analysis.
Hiraki Y; Onga T; Mizoguchi A; Tsuji Y
J Clin Pharm Ther; 2010 Oct; 35(5):527-32. PubMed ID: 20831677
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.
Jaksic B; Martinelli G; Perez-Oteyza J; Hartman CS; Leonard LB; Tack KJ
Clin Infect Dis; 2006 Mar; 42(5):597-607. PubMed ID: 16447103
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin pharmacokinetics in patients with severe burn injuries.
Dolton M; Xu H; Cheong E; Maitz P; Kennedy P; Gottlieb T; Buono E; McLachlan AJ
Burns; 2010 Jun; 36(4):469-76. PubMed ID: 19875238
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
Foote EF; Dreitlein WB; Steward CA; Kapoian T; Walker JA; Sherman RA
Clin Nephrol; 1998 Jul; 50(1):51-5. PubMed ID: 9710347
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin peak serum concentration monitoring.
Tam VH; Moore GE; Triller DM; Briceland LL
J Intraven Nurs; 1999; 22(6):336-42. PubMed ID: 10865602
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients.
Chaftari AM; Hachem R; Mulanovich V; Chemaly RF; Adachi J; Jacobson K; Jiang Y; Raad I
Int J Antimicrob Agents; 2010 Aug; 36(2):182-6. PubMed ID: 20452752
[TBL] [Abstract][Full Text] [Related]
10. Influence of glomerular filtration rate on the clearance of vancomycin administered by continuous infusion in burn patients.
Dailly E; Le Floch R; Deslandes G; Pannier M; Jolliet P
Int J Antimicrob Agents; 2008 Jun; 31(6):537-9. PubMed ID: 18462925
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenation.
Mulla H; Pooboni S
Br J Clin Pharmacol; 2005 Sep; 60(3):265-75. PubMed ID: 16120065
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations.
Thomson AH; Staatz CE; Tobin CM; Gall M; Lovering AM
J Antimicrob Chemother; 2009 May; 63(5):1050-7. PubMed ID: 19299472
[TBL] [Abstract][Full Text] [Related]
13. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.
Lodise TP; Patel N; Lomaestro BM; Rodvold KA; Drusano GL
Clin Infect Dis; 2009 Aug; 49(4):507-14. PubMed ID: 19586413
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of serum vancomycin concentrations in pediatric patients with normal renal function.
Khotaei GT; Jam S; SeyedAlinaghi S; Motamed F; Nejat F; Taghi M; Ashtiani H; Izadyar M
Acta Med Iran; 2010; 48(2):91-4. PubMed ID: 21133000
[TBL] [Abstract][Full Text] [Related]
15. Concentrations of vancomycin in human bone.
Borner K; Hahn F; Koeppe P
J Chemother; 1989 Jul; 1(4 Suppl):588-9. PubMed ID: 16312546
[No Abstract] [Full Text] [Related]
16. Weight-based loading of vancomycin in patients on hemodialysis.
Brown M; Polisetty R; Gracely EJ; Cuhaci B; Schlecht HP
Clin Infect Dis; 2011 Jul; 53(2):164-6. PubMed ID: 21690623
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of vancomycin in patients undergoing haemodialysis and haemofiltration.
De Bock V; Verbeelen D; Maes V; Sennesael J
Nephrol Dial Transplant; 1989; 4(7):635-9. PubMed ID: 2510061
[TBL] [Abstract][Full Text] [Related]
18. [Bacteremia due to vancomycin-resistant enterococci in neutropenic cancer patients].
Marron A; Carratalà J; Ayats J; Fernández de Sevilla A; Domínguez MA; Liñares J; Gudiol F
Med Clin (Barc); 1998 Dec; 111(20):761-4. PubMed ID: 9922964
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the value of empiric vancomycin administration in febrile neutropenia occurring after autologous peripheral blood stem cell transplants.
Koya R; Andersen J; Fernandez H; Goodman M; Spector N; Smith R; Hanlon J; Cassileth PA
Bone Marrow Transplant; 1998 May; 21(9):923-6. PubMed ID: 9613785
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin dosing in obese pediatric patients.
Moffett BS; Kim S; Edwards MS
Clin Pediatr (Phila); 2011 May; 50(5):442-6. PubMed ID: 21282257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
